Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder-Reference-Cited by-同舟云学术

Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder

Published:2021-05-31 Issue:2 Volume:19 Page:243-253
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Shin Cheolmin¹^ORCID,Pae Chi-Un²^ORCID,Kwak Kyung Phil³^ORCID,Jeon Sang Won⁴^ORCID,Jeong Hyun-Ghang¹^ORCID,Kim Jong-Woo⁵^ORCID,Lee Youn Jung⁶^ORCID,Patkar Ashwin A.⁷^ORCID,Han Changsu¹^ORCID

Affiliation:

1. Department of Psychiatry, Korea University College of Medicine, Seoul, Korea

2. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea

3. Department of Psychiatry, Dongguk University Gyeongju Hospital, Gyeongju, Korea

4. Department of Psychiatry, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea

5. Department of Psychiatry, Kyung Hee University School of Medicine, Seoul, Korea

6. Department of Psychiatry, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Korea

7. Department of Psychiatry and Behavioural Sciences, Duke University Medical Center, Durham, NC, USA

Funder

Korea Otsuka Pharmaceutical

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2021/019/cpn019-02-06.pdf

Reference61 articles.

1. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

2. Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder

3. A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy

4. Response and remission criteria in major depression – A validation of current practice

5. Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functioning in patients with major depressive disorder in remission: A systematic review and meta-analysis;Journal of Affective Disorders;2024-10

2. The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting;Clinical Psychopharmacology and Neuroscience;2024-02-04

3. Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder;Clinical Psychopharmacology and Neuroscience;2023-08-31

4. Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting;Clinical Psychopharmacology and Neuroscience;2023-08-31

5. Use of the Third-Generation Atypical Antipsychotic Aripiprazole (Zylaxera®) for Treatment of Depressive States in Schizophrenia: Efficacy and Safety Study;Psikhiatriya;2023-06-19